Immunotherapy for metastatic melanoma-from little benefit to first-line treatment

CG Mutz-Rabl; P Koelblinger; L Koch

doi:10.1007/s12254-023-00881-6

Immunotherapy for metastatic melanoma-from little benefit to first-line treatment

CG Mutz-Rabl, P Koelblinger (Co-author), L Koch

Department of Dermatology and Allergology

Research output: Contribution to journal › Review article › peer-review

Original language	English
Journal	memo - Magazine of European Medical Oncology
DOIs	https://doi.org/10.1007/s12254-023-00881-6
Publication status	Published - 2023

Keywords

HIGH-RISK
COMBINED NIVOLUMAB
ADJUVANT THERAPY
STAGE-III
IPILIMUMAB
PEMBROLIZUMAB
MULTICENTER

Access to Document

10.1007/s12254-023-00881-6

Cite this

@article{56b7e1ae6c8a4b7788eaa2131047e1e9,

title = "Immunotherapy for metastatic melanoma-from little benefit to first-line treatment",

keywords = "HIGH-RISK, COMBINED NIVOLUMAB, ADJUVANT THERAPY, STAGE-III, IPILIMUMAB, PEMBROLIZUMAB, MULTICENTER",

author = "CG Mutz-Rabl and P Koelblinger and L Koch",

note = "Koelblinger: Department of Dermatology and Allergology, Salzburger Landeskliniken/Paracelsus Medical University, M{\"u}llner Hauptstra{\ss}e 48, 5020 Salzburg, Austria",

year = "2023",

doi = "10.1007/s12254-023-00881-6",

language = "English",

journal = "memo - Magazine of European Medical Oncology",

issn = "1865-5041",

publisher = "Springer Verlag",

}

TY - JOUR

T1 - Immunotherapy for metastatic melanoma-from little benefit to first-line treatment

AU - Mutz-Rabl, CG

AU - Koelblinger, P

AU - Koch, L

N1 - Koelblinger: Department of Dermatology and Allergology, Salzburger Landeskliniken/Paracelsus Medical University, Müllner Hauptstraße 48, 5020 Salzburg, Austria

PY - 2023

Y1 - 2023

KW - HIGH-RISK

KW - COMBINED NIVOLUMAB

KW - ADJUVANT THERAPY

KW - STAGE-III

KW - IPILIMUMAB

KW - PEMBROLIZUMAB

KW - MULTICENTER

U2 - 10.1007/s12254-023-00881-6

DO - 10.1007/s12254-023-00881-6

M3 - Review article

SN - 1865-5041

JO - memo - Magazine of European Medical Oncology

JF - memo - Magazine of European Medical Oncology

ER -